Figure 2From: Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer Platelet count and corresponding corresponding serum CA 125 patient 2. Carboplatin AUC 3/paclitaxel 75 mg/m2 (white bars). Dose omission (black columns). Carboplatin AUC 3/paclitaxel 20 mg/m2 (hatched bars). Serum CA 125 (solid line).Back to article page